Creating synthetic circuits to control cell differentiation for blood cell production
Synthetic Genetic Controller Circuits for Transcription Factor-Directed Differentiation
This study is working on a new way to help turn special stem cells into specific types of blood cells more effectively, which could lead to better treatments for patients needing blood-related therapies.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Massachusetts Institute of Technology NIH-funded |
| Lab location | 1 site (Cambridge, United States) |
| Project ID | NIH-11117441 on NIH RePORTER |
What this research studies
This research aims to develop synthetic genetic circuits that can autonomously regulate the expression of transcription factors critical for differentiating human induced pluripotent stem cells (hiPSCs) into specific blood cell types. By improving the efficiency and consistency of this differentiation process, the research seeks to address current challenges in producing hematopoietic stem and progenitor cells, which are essential for various blood-related therapies. The approach involves optimizing the timing and levels of transcription factor expression to enhance the quality of the resulting cells. Patients may benefit from advancements in cell therapy and regenerative medicine as a result of this work.
Who could benefit from this research
Good fit: Ideal candidates for participation or benefit from this research would include individuals with blood-related conditions who may require stem cell therapies.
Not a fit: Patients with conditions unrelated to blood cell production or those who are not eligible for stem cell therapies may not receive benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to more efficient and reliable production of blood cells for therapies, improving treatment options for patients with blood disorders.
How similar studies have performed: Previous research has shown promise in using synthetic genetic circuits for cell differentiation, indicating potential for success in this novel approach.
Where this research is happening
Cambridge, United States
- Massachusetts Institute of Technology — Cambridge, United States (Active)
Researchers
- Principal investigator: Del Vecchio, Domitilla — Massachusetts Institute of Technology
- Study coordinator: Del Vecchio, Domitilla
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.